Longeveron (LGVN) Cost of Revenue (2020 - 2026)

Longeveron's (LGVN) quarterly Cost of Revenue came in at $134000.0 in Q1 2026, up 26.42% year-on-year from $106000.0 in Q1 2025, and up 24.07% quarter-over-quarter from $108000.0 in Q4 2025.

Longeveron (LGVN) Cost of Revenue (2020 - 2026) Analysis & Trends

Longeveron's Cost of Revenue history runs 7 years deep, the most recent figure standing at $134000.0 for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 26.42% year-over-year to $134000.0 in Q1 2026; TTM through Mar 2026 was $424000.0, a 7.61% increase from a year earlier, with the FY2025 full-year figure at $396000.0, down 22.05% from the prior year.
  • Cost of Revenue grew to $134000.0 in Q1 2026 per LGVN's latest filing, from $108000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $306000.0 in Q2 2022 and bottomed at $12000.0 in Q3 2025.
  • The 5-year median for Cost of Revenue is $124000.0 (2023), against an average of $140294.1.
  • Across the five-year window, Cost of Revenue soared 154.41% in 2022 and tumbled 86.81% in 2025, its largest moves.
  • Year by year, Cost of Revenue stood at $176000.0 in 2022, then tumbled by 63.07% to $65000.0 in 2023, then rose by 12.31% to $73000.0 in 2024, then soared by 47.95% to $108000.0 in 2025, then increased by 24.07% to $134000.0 in 2026.
  • Per Business Quant, the three latest LGVN Cost of Revenue figures stand at $134000.0 (Q1 2026), $108000.0 (Q4 2025), and $12000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 167.22 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 392.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 296.00 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 145.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Longeveron 15.18 Bn 15.16 Bn 264,000.00 134,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 134,000.00
Mar 31, 2026 134,000.00
Dec 31, 2025 108,000.00
Dec 31, 2025 108,000.00
Sep 30, 2025 12,000.00
Sep 30, 2025 12,000.00
Jun 30, 2025 170,000.00
Jun 30, 2025 170,000.00
Mar 31, 2025 106,000.00
Mar 31, 2025 106,000.00
Dec 31, 2024 73,000.00
Dec 31, 2024 73,000.00
Sep 30, 2024 91,000.00
Sep 30, 2024 91,000.00
Jun 30, 2024 124,000.00
Jun 30, 2024 124,000.00
Mar 31, 2024 219,000.00
Mar 31, 2024 219,000.00
Dec 31, 2023 65,000.00
Dec 31, 2023 65,000.00